Medtronic Freestyle Valve Durability Claim Discussions With FDA Are Ongoing
This article was originally published in The Gray Sheet
Executive Summary
Medtronic and FDA are discussing both the data requirements to substantiate durability claims for the Freestyle heart valve and currently appropriate statements for promotional and advertising materials in the wake of a May 12 warning letter from the agency.